Market Place
Sourcing Support
All News #Library
Biotech
BioSenic provides third quarter 2024 Business Update
28 Oct 2024 //
GLOBENEWSWIRE
BioSenic Transparency notification received from ABO Infinium OpCo
07 Oct 2024 //
GLOBENEWSWIRE
BioSenic Receives Transparency Notification From ABO Infinium Americas OpCo
19 Aug 2024 //
GLOBENEWSWIRE
BioSenic Receives Transparency Notification From ABO Infinium Americas
13 Aug 2024 //
GLOBENEWSWIRE
Medsenic/BioSenic Granted Patent In Japan For Therapeutic Platform
13 Aug 2024 //
GLOBENEWSWIRE
BioSenic presents new Phase 3 data on JTA-004
25 Jan 2024 //
GLOBENEWSWIRE
BioSenic files for additional patent protection for JTA-004 in osteoarthritis
22 Jan 2024 //
GLOBENEWSWIRE
BioSenic plots path past biotech graveyard and into phase 3
25 Oct 2023 //
FIERCE BIOTECH
BioSenic reacquires global IP rights and provides update on JTA-004 development
17 May 2023 //
GLOBENEWSWIRE
BioSenic identifies key biomarkers for cGvHD and submits patent to EPO
03 May 2023 //
GLOBENEWSWIRE
BioSenic delivers a new post-hoc analysis of its Phase III JTA-004 trial
16 Mar 2023 //
GLOBENEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.